| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTCT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $77.68M | -5,000 | |
| CEO | 383.9K | $26.32M | - | |
| VP | 105.3K | $6.76M | -2,265 | |
| CFO | 84.0K | $6.75M | - | |
| VP | 79.1K | $5.38M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Pauwels Eric61 | Chief Business Officer | Sell10b5-1 | 3,141 | $77.18 | $242,416.51 | -3.5% | -9.9% | - | |
| Jan 7, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell10b5-1 | 2,616 | $77.19 | $201,918.70 | -3.4% | -9.9% | - | |
| Jan 7, 2026 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 8,165 | $77.15 | $629,895.23 | -2.0% | -9.9% | - | |
| Jan 7, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell10b5-1 | 1,982 | $77.12 | $152,855.16 | -2.1% | -9.9% | - | |
| Jan 6, 2026 | Gravier Pierre55 | Chief Financial Officer | Sell10b5-1 | 2,139 | $76.95 | $164,596.05 | -2.3% | -10.2% | - | |
| Jan 5, 2026 | Reeve Emma73 | Director | Sale+OE10b5-1 | 734 | $76.00 | $55,784.00 | -6.4% | -10.2% | - | |
| Jan 5, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 2,266 | $75.55 | $171,191.98 | -1.8% | -10.2% | - | |
| Jan 2, 2026 | Steele Glenn Jr Md Phd | Director | Sale+OE10b5-1 | 12,000 | $76.35 | $916,200.00 | -39.3% | -11.7% | - | |
| Dec 30, 2025 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 8,089 | $76.64 | $619,940.96 | -2.3% | -13.8% | - | |
| Dec 19, 2025 | Pauwels Eric61 | Chief Business Officer | Sale+OE10b5-1 | 20,508 | $77.26 | $1,584,349.85 | -22.6% | -14.6% | - |